Anti-inflammatory therapeutics: Conventional concepts and future with nanotechnology

Author:

Kaur Pawan1,Bernela Manju2,Kaushal Priya2,Verma Naveen2,Thakur Rajesh3,Ahuja Munish4

Affiliation:

1. Skill-Faculty of Agriculture, Shri Vishwakarma Skill University, Gurugram-122004, India

2. Department of Biotechnology, Guru Nanak Dev University, Amritsar-143001, India

3. Department of Bio and Nanotechnology, Guru Jambheshwar University of Science and Technology, Hisar-125001, India

4. Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar-125001, India

Abstract

Abstract: With the advent of globalization, there has been a continuous increase in the risk of inflammatory diseases which in turn leads to the maximum usage of anti-inflammatory drugs. Currently, drugs used for anti-inflammatory therapies are costly with low efficacy, high health risk, and socio-economic impact due to the concern issue of their toxicity. Recently, nano-drug delivery system has been experiencing foremost interest as a new approach for targeting therapeutic agents to the target sites in a controlled, sustained manner and has various advantages as compared to the conventional drug delivery system like increased solubility, bioavailability, improves pharmacokinetic profile of drugs, surface area and rate of dissolution and additionally, overcomes the problems related to hydrophobicity, toxicity.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3